King F - Search Results

1

Introduction of a dose-banding system for parenteral chemotherapy on a haematology-oncology day ward.

O'Leary CE, Collins A, Henman MC, King F. O'Leary CE, et al. Among authors: king f. J Oncol Pharm Pract. 2019 Mar;25(2):351-361. doi: 10.1177/1078155217736376. Epub 2017 Oct 23. J Oncol Pharm Pract. 2019. PMID: 29059028

2

Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.

Hammond L, Marsden E, O'Hanlon N, King F, Henman MC, Keane C. Hammond L, et al. Among authors: king f. Int J Clin Pharm. 2012 Dec;34(6):893-901. doi: 10.1007/s11096-012-9688-1. Epub 2012 Sep 9. Int J Clin Pharm. 2012. PMID: 22961608

3

Cytotoxic chemotherapy for pregnancy-associated breast cancer: single institution case series.

Morris PG, King F, Kennedy MJ. Morris PG, et al. Among authors: king f. J Oncol Pharm Pract. 2009 Dec;15(4):241-7. doi: 10.1177/1078155209103096. J Oncol Pharm Pract. 2009. PMID: 19304882

4

Prenatal and perinatal risk factors for neuroblastoma. A case-control study.

Neglia JP, Smithson WA, Gunderson P, King FL, Singher LJ, Robison LL. Neglia JP, et al. Among authors: king fl. Cancer. 1988 Jun 1;61(11):2202-6. doi: 10.1002/1097-0142(19880601)61:11<2202::aid-cncr2820611113>3.0.co;2-7. Cancer. 1988. PMID: 3365650

5

Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia.

Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia JP. Kaye SA, et al. Among authors: king fl. Cancer. 1991 Sep 15;68(6):1351-5. doi: 10.1002/1097-0142(19910915)68:6<1351::aid-cncr2820680627>3.0.co;2-j. Cancer. 1991. PMID: 1873786

6

Birth weight as a risk factor for childhood acute lymphoblastic leukemia.

Robison LL, Codd M, Gunderson P, Neglia JP, Smithson WA, King FL. Robison LL, et al. Among authors: king fl. Pediatr Hematol Oncol. 1987;4(1):63-72. doi: 10.3109/08880018709141250. Pediatr Hematol Oncol. 1987. PMID: 3152913

7

Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access.

O'Leary C, Schultz C, Walsh C, Adams R, Casey D, Lane S, Harrison M, Doyle S, Costello RW, King F, Murphy DM. O'Leary C, et al. Among authors: king f. BMJ Open Respir Res. 2022 Sep;9(1):e001341. doi: 10.1136/bmjresp-2022-001341. BMJ Open Respir Res. 2022. PMID: 36167473 Free PMC article.

8

Advancing ketamine in the treatment hierarchy for refractory depression.

Nigam K, King F 4th, Espi Forcen F. Nigam K, et al. Among authors: king f 4th. Br J Psychiatry. 2024 Oct 25:1-3. doi: 10.1192/bjp.2024.217. Online ahead of print. Br J Psychiatry. 2024. PMID: 39449651

9

Talking to Your Patients About Psychedelics: Using an Informed Approach and Understanding Indications, Risks, and Benefits.

King F, Nahlawi A, Stern TA. King F, et al. Prim Care Companion CNS Disord. 2024 Oct 15;26(5):24f03783. doi: 10.4088/PCC.24f03783. Prim Care Companion CNS Disord. 2024. PMID: 39441967 Free article.

10

A pathogen effector co-opts a host RabGAP protein to remodel pathogen interface and subvert defense-related secretion.

Yuen ELH, Tumtas Y, King F, Ibrahim T, Chan LI, Evangelisti E, Tulin F, Skłenar J, Menke FLH, Kamoun S, Bubeck D, Schornack S, Bozkurt TO. Yuen ELH, et al. Among authors: king f. Sci Adv. 2024 Oct 4;10(40):eado9516. doi: 10.1126/sciadv.ado9516. Epub 2024 Oct 4. Sci Adv. 2024. PMID: 39365859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters